Session » (1996–2018) Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster
- 9:00AM-11:00AM
-
Abstract Number: 1997
A Randomized, Double-blind, Phase III Study to Compare SB16 (Proposed Denosumab Biosimilar) to Reference Denosumab in Patients with Postmenopausal Osteoporosis
- 9:00AM-11:00AM
-
Abstract Number: 2010
B-FROST: Chronic OBstructive Pulmonary Disease and Vertebral FRacture of OSTeoporotic Origin: Results of a Real-life Cohort
- 9:00AM-11:00AM
-
Abstract Number: 2004
Bone Health Following Bariatric Surgery: A Single Center Quality Improvement Study
- 9:00AM-11:00AM
-
Abstract Number: 2001
Burden of Metabolic Bone Disease in Patients with IgG4-Related Disease with and Without Autoimmune Pancreatitis
- 9:00AM-11:00AM
-
Abstract Number: 2013
Clinical Characteristics and Risk Factors Associated with Fragility Fractures in Patients with Primary and Idiopathic Mast Cell Activation Syndromes
- 9:00AM-11:00AM
-
Abstract Number: 2008
Comparative Effectiveness of Denosumab versus Alendronate Among Postmenopausal Women with Osteoporosis in the U.S. Medicare Program
- 9:00AM-11:00AM
-
Abstract Number: 2002
Cost-Effectiveness Analysis of Sequential Treatment with Abaloparatide Followed by Alendronate in US Women and Men with Multiple Previous Fractures
- 9:00AM-11:00AM
-
Abstract Number: 2018
Development of an Osteoporosis Treatment Gap Dashboard
- 9:00AM-11:00AM
-
Abstract Number: 2003
Effects of Abaloparatide on Cortical and Trabecular Compartments by 3D-DXA in Men with Osteoporosis
- 9:00AM-11:00AM
-
Abstract Number: 2007
Effects of IL-17 Blockade on Skeletal Microarchitecture in Patients with Axial Spondyloarthritis: An HR-pQCT Study
- 9:00AM-11:00AM
-
Abstract Number: 2000
Efficacy of Romosozumab for Glucocorticoid-induced Osteoporosis in Patients with Rheumatic Diseases; A Prospective Study
- 9:00AM-11:00AM
-
Abstract Number: 2016
Generation of a Human 3D in Vitro Bone Model That Mimics Glucocorticoid-induced Osteoporosis
- 9:00AM-11:00AM
-
Abstract Number: 1998
How to Tailor Osteoporosis Therapies in Patients with Advanced Liver Disease? Variations of Renal Function by Creatinine and Cystatin C
- 9:00AM-11:00AM
-
Abstract Number: 2006
Improvement of Care: Osteoporosis Screening in a Resident-led Primary Care Clinic
- 9:00AM-11:00AM
-
Abstract Number: 2012
Incidence of Hyperparathyroidism in Patients with Osteoporosis Treated with Zoledronic Acid or Denosumab
- 9:00AM-11:00AM
-
Abstract Number: 2017
Lupus Nephritis Is Strongly Associated with Low Bone Mineral Density and Osteoporosis in Patients with Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 1999
One-year Incidence of Clinical Fragility Fractures After Implementing an Osteoporosis Care Protocol in Patients Eligible for Liver Transplantation
- 9:00AM-11:00AM
-
Abstract Number: 2011
Predicting Fractures in Patients with Isolated Lumbar Spine Osteoporosis Compared to Those with Isolated Hip Osteoporosis
- 9:00AM-11:00AM
-
Abstract Number: 2009
Screening and Treatment of Low Bone Mineral Density in Allogeneic Hematopoietic Cell Transplant Patients
- 9:00AM-11:00AM
-
Abstract Number: 2005
Secondary Prevention of Osteoporosis in Hip Fracture Care for Elderly Patients. Clinical and Functional Profile of Users
- 9:00AM-11:00AM
-
Abstract Number: 2015
Synergistic Effect Between Denosumab and Immune Checkpoint Inhibitors : A Retrospective Study of 268 Patients with Bone Metastases
- 9:00AM-11:00AM
-
Abstract Number: 2014
The Role of Orosomucoid 2 in the Regulation of Bone Remodeling by Inhibiting Osteoclastogenesis and Promoting Osteogenesis
- 9:00AM-11:00AM
-
Abstract Number: 1996
Variation in Dual-energy X-ray Absorptiometry Reporting: A National Survey of Veterans Health Administration Clinics